Stroke is a devastating complication of both coronary artery bypass grafting (CABG) surgery
and percutaneous coronary intervention (PCI). In a recent survey of 3112 cardiac patients by …

Background Bivalirudin is an alternative accepted therapy to unfractionated heparin for
patients with myocardial infarction (MI) undergoing percutaneous coronary intervention …

Background We aimed to compare the efficacy and safety of bivalirudin versus heparin as
the anticoagulant in patients undergoing extracorporeal membrane oxygenation (ECMO) …

Objectives To assess the efficacy and safety of transradial (TR) versus transfemoral (TF)
percutaneous coronary intervention (PCI) in left main (LM) lesion. Background TR‐PCI is the …

Background It is clinically important to identify high-risk patients with acute coronary
syndrome (ACS) who may require repeat revascularization. This retrospective study …

Coronary artery disease is one of the most common dysfunctions of the cardiovascular
system [1]. Anticoagulant therapy is particularly important in the periprocedural period in the …

目的观察比伐卢定联合低分子肝素在急性脑梗死机械取栓术后抗凝治疗中的应用效果.
方法采用前瞻性巢式病例研究法, 以血管内机械取栓术后接受低分子肝素抗凝治疗的急性脑梗死 …

Objectives The goal of this study was to report a multicenter series of left-sided catheter
ablations performed by using intravenous direct thrombin inhibitors (DTIs) as an alternative …

Background There is ongoing uncertainty regarding the safety and efficacy of unfractionated
heparin and bivalirudin when used for systemic anticoagulation in patients undergoing …

This meta‐analysis was performed to compare the safety, efficacy, and pharmacoeconomic
of bivalirudin versus heparin in high‐risk patients for percutaneous coronary interventions …